Galapagos NV
F:GXEA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Galapagos NV
F:GXEA
|
BE |
|
S
|
Sabra Health Care REIT Inc
SWB:SBC
|
US |
|
P
|
Parker-Hannifin Corp
XMUN:PAR
|
US |
|
A
|
Aluminum Corporation of China Ltd
XMUN:AOC
|
CN |
|
United Utilities Group PLC
LSE:UU
|
UK |
|
Gladstone Land Corp
F:3L4
|
US |
Wall St Price Targets
GXEA Price Targets Summary
Galapagos NV
According to Wall Street analysts, the average 1-year price target for
GXEA is 29.6 EUR with a low forecast of 18.83 EUR and a high forecast of 46.15 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GXEA's stock price target?
Price Target
29.6
EUR
According to Wall Street analysts, the average 1-year price target for
GXEA is 29.6 EUR with a low forecast of 18.83 EUR and a high forecast of 46.15 EUR.
What is the Revenue forecast for Galapagos NV?
Projected CAGR
-44%
Over the last 14 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 8 years is -44%.